Cerluten®
In patients with the consequences of traumatic brain injury and stroke, there was a moderate re-
gression of focal symptoms, improved speech function with motor and sensory aphasia, and de-
creased muscle spasticity.
Comparative assessment of the influence of CERLUTEN® and other treatment methods on the
integral function of the brain - attention and bioelectrical activity of the brain were studied using a
corrective test and electroencephalography, respectively.
Influence of CERLUTEN® on the subjective indicators of the health Table 3
status of patients.
Indicator Before Treatment, % After Treatment using After Treatment using
Conventional Means, % Cerluten®
Headaches 76,6 47,2# 34,1#
Sleep disturbance 54,9 34,0# 24,3#
Emotional lability 75,8 43,0# 21,4*#
Memory impairment 54,5 45,2 28,5*#
Absent-mindedness 48,7 43,9 14,6*#
Fast fatiguability 72,0 53,2# 32,4*#
# P <0.05 compared with the indicator in patients before treatment;
* P <0.05 compared with the indicator in patients after treatment with conventional means..
Influence of CERLUTEN® on the dynamics of indicators of performing the Table 4
correction test by patients with diseases of the central nervous system.
Examined group Quantity of viewed characters Quantity of mistakes
Healthy 1835,2±83,7 7,15±1,01
Patients before treatment 1143,7±75,4 18,12±0,93
Patients after treatment with conventional means 1573,8±67,5* 11,1±0,86*
Patients after treatment with CERLUTEN® 1682,6± 62,8*# 8,67± 0,96*#
* Р<0.05 compared with the indicator in the group of patients before treatment;
# P<0.05 compared with the indicator in the group of patients after treatment with conventional means.
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.